Serum XXXX levels in newborns of @entity6 and @entity101 mothers.

@entity398 @entity1 @entity101 @entity6 @entity648
The aim of this study was to investigate the effect of @entity398 induction and augmentation on neonatal @entity648 levels in newborns of @entity6 and @entity101 mothers. All @entity1 included in the study were admitted to the obstetrics department at Al Hussein Hospital. They were 18-38 years old, and their gestational ages were 38-41 weeks by date. A total number of 140 newborn @entity1 were divided into 3 groups and studied for @entity648 levels. The first group consisted of 40 @entity1 of @entity6 mothers, 20 of whom were given @entity398 for labor induction and 20 of whom received it for labor augmentation. The second group consisted of 40 @entity1 of @entity101 mothers, 20 of whom were given @entity398 for labor induction and 20 of whom received it for labor augmentation. The third group consisted of 60 controls, 20 of whom were given @entity398 for labor induction, 20 of whom received it for labor augmentation, and 20 of whom received no @entity398 . It was found that total and unconjugated @entity648 levels were higher in @entity1 delivered after induction of labor, whether their mothers were @entity6 , @entity101 , or neither, than in @entity1 delivered without labor induction. @entity648 levels were mildly high in @entity1 of @entity6 mothers after augmented delivery and then nullified after 24 hours. However, the study suggested that the increased @entity648 levels were related to induced labor rather than the medical problem of the mothers, provided that the newborns were of average weight.
